Skip to content

Neuromodulation in Obesity

Neuromodulation in Obesity - NiObe

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029372
Enrollment
60
Registered
2022-07-05
Start date
2022-07-11
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.0

Interventions

Group 1: 2x 10 min. transcranial Random Noise Stimulation (tRNS) Group 2: 2x 10 min. Sham Stimulation

Sponsors

Charité - Universitätsmedizin Berlin,Klinik für Endokrinologie, Diabetes und Stoffwechselmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Obesity (BMI > 30 kg/m²)

Exclusion criteria

Exclusion criteria: Pregnancy and lactation, photosensitive epilepsy, electronic/ferromagnetic implantats, Diabetes mellitus Type 1/2

Design outcomes

Primary

MeasureTime frame
Food-Related Attentional Bias (Pictorial Dot Probe Task) each visit before and after stimulation (tRNS or Sham) and after food intake

Secondary

MeasureTime frame
Neurophysiological changes (EEG) each visit before and after stimulation (tRNS or Sham) and after food consumption. Total food intake and self-reported food craving each visit after stimulation (tRNS or Sham) and food intake.

Countries

Germany

Contacts

Public ContactLinus Haberbosch

Charité - Universitätsmedizin Berlin,Klinik für Endokrinologie, Diabetes und Stoffwechselmedizin

ambulanz-endokrinologie@charite.de+4930450614264

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026